Our Cases

Compass Lexecon has been involved in many of the largest and most complex antitrust litigation and financial market cases over the past 30 years.

Find a Case

Sorry, your search didn't return any results.

10/18/17

After deliberating for less than one hour, a jury cleared Compass Lexecon's client, headset manufacturer Plantronics, on all counts in an antitrust suit filed five years ago by competitor GN Netcom, maker of the Jabra brand of headsets. GN alleged...

09/26/16

On September 26, 2016, the U.S. Second Circuit Court of Appeals ruled in favor of American Express in U.S. et al. v. American Express Co. et al. The Second Circuit reversed and remanded, with instructions to enter judgment in favor...

01/09/12

On January 9, 2012, the Superior Court of California (County of Santa Clara) granted a complete victory to Compass Lexecon’s client, DVD CCA. The Court ruled that Kaleidescape, a manufacturer of DVD movie servers, breached its license agreement with DVD...

05/30/11

In late May 2011, IBM and Neon Enterprise Software LLC reached a settlement widely regarded as very favorable to Compass Lexecon’s client, IBM. At the heart of the dispute was a software product, zPrime, offered by Neon that allowed IBM’s...

05/27/10

Professor Daniel Rubinfeld led a Compass Lexecon team working on behalf of Google in connection with its proposed acquisition of mobile-advertising network AdMob. Professor Rubinfeld was supported by Jim Ratliff and Sarah Bartlett in the Oakland office. We submitted white...

03/29/10

On March 29, 2010, Cisco Systems, Inc. received approval from the European Commission for its proposed acquisition of Tandberg ASA, the largest provider of videoconferencing equipment in the world. On that same day, the Department of Justice announced that it...

10/14/09

Pfizer Inc. and the law firms of Morgan, Lewis & Bockius LLP and Cadwalader, Wickersham & Taft LLP retained Compass Lexecon to provide economic analysis in connection with the successful merger of Pfizer and Wyeth. Valued at about $65 billion,...

08/30/09

In August 2009, U.S. District Court Judge Robert T. Dawson ruled in favor of Compass Lexecon’s client CHEP USA by denying plaintiffs’ motion for class certification in a suit alleging that CHEP violated Sherman Act Section 2 through its alleged...

11/21/08

Direct purchasers, indirect purchasers, and generic manufacturers sued Abbott Laboratories and Fournier in these cases alleging that the introduction of new formulations (and subsequent delisting of the old formulations) of the cholesterol drug TriCor harmed competition by hindering generic manufacturers’...